diaTribe

Type 1 diabetes screening typically requires a blood test. Geneticist Yuta Matsuda, founder of T1D Scout, developed an at-home test that starts with a saliva swab instead. If the test shows higher genetic risk, families can follow up with at-home antibody testing. Matsuda said the goal is to make screening easier to access and more likely to be completed – especially for families who may have trouble getting to a research site or completing a blood test with a young child.

GLP-1 receptor agonists like Ozempic and Mounjaro have reshaped the conversation around weight loss and diabetes management. Now, a growing number of people are experimenting with something even further outside the guidelines: taking these medications at a fraction of the approved dose. Microdosing, which means taking a medication at a dose smaller than the approved dose, is not FDA-approved, but has gained traction on social media, in wellness circles, and now, in clinical conversations.

This educational article was made possible with materials and support from Tandem Diabetes Care. Automated insulin delivery (AID) systems have been traditionally used by people with type 1 diabetes but are now more widely available for those with type 2 diabetes after the approval of several major systems in 2025, including the Tandem Diabetes Care t:slim X2 insulin pump and Tandem Mobi system with Control-IQ+ technology, the predictive algorithm with research-proven results.

Key takeaways: Many important molecules in the body are peptides. Some peptides, like GLP-1, can be modified into effective medications for a variety of conditions, including diabetes. Recently, health, wellness, and fitness influencers have been touting the benefits of unapproved peptides that are often sold “for research purposes only.” If a peptide has not been approved as a medication, then taking it can be risky and potentially ineffective.

People with diabetes sometimes hear comments from coworkers that can feel hurtful or judgmental. Routine care, like taking insulin or checking glucose, sometimes feels conspicuous, and coworkers' lack of understanding may leave people feeling like they're being judged, treated differently, or seen as less capable. Like others with diabetes, I've felt primarily acceptance and support from coworkers as I juggled type 1 along with my workload in half a dozen offices.

Diabetes and Weight Management Treatments New Experimental Drug Leads To Dramatic Weight Loss and Relief From Related Conditions GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently developing retatrutide, the first drug to target receptors for three hormones: GLP-1, GIP, and glucagon.

Trial Status: Recruiting Clinical Trials Identifier: NCT07187531 Trial Name: SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes (SAFEGUARD) Diabetes Type: Type 1 diabetes Trial Sponsor: SAB Biotherapeutics, Inc. Why is this study important? This study is testing the effectiveness of a new antibody drug, SAB-142, for slowing the progression of stage 3 type 1 diabetes, when insulin therapy becomes necessary.

People with type 1 diabetes face significant challenges managing glucose, weight, and complication risks, but have very few approved treatment options. Even with advances in insulin formulations and advanced technologies, type 1 diabetes remains complex and demanding to manage, and elevated glucose levels are common. The prolonged high blood sugars that define diabetes carry the same complication risks in both type 1 and type 2 diabetes.

My love for running and my journey with diabetes are intertwined stories: it is hard to talk about one without including the other. When I was 13, I transitioned from a small private school to a large public school. I thought joining a sport would be an easy way to make new friends, and I joined the school’s cross-country team. Two weeks after joining the team, something was wrong.

To start, what exactly is diabetes self-management education and support (DSMES)? DSMES is the ongoing process of gaining the knowledge, skills, and abilities necessary for diabetes self-care. DSMES is a process guided by evidence-based standards that incorporates the needs, goals, and life experiences of each person with diabetes.